BioStock: Alligator’s CMO hosts in-depth webinar on Mitazalimab

At the beginning of the year, Alligator BioScience presented promising interim data from its OPTIMIZE-1 phase II study in metastatic pancreatic cancer. To put further emphasis on the study design and importance of these results, the Swedish biotech hosted a webinar featuring Alligator’s CMO Sumeet Ambarkhane and Jean-Luc Van Laethem, who is Principal Investigator for the study. BioStock spoke with Dr Ambarkhane to learn more.

Läs hela intervjun med Sumeet Ambarkhane på biostock.se:

Alligator’s CMO hosts in-depth webinar on Mitazalimab - BioStock

Detta är ett pressmeddelande från BioStock – Connecting Innovation & Capital. https://www.biostock.se